(12) International Application Status Report

Received at International Bureau: 17 April 2020 (17.04.2020)

Information valid as of: 15 October 2020 (15.10.2020)

Report generated on: 26 January 2021 (26.01.2021)

(10) Publication number: (43) Publication date: (26) Publication language:
WO 2020/20547708 October 2020 (08.10.2020) English (EN)

(21) Application number: (22) Filing date: (25) Filing language:
PCT/US2020/02513127 March 2020 (27.03.2020) English (EN)

(31) Priority number(s): (32) Priority date(s): (33) Priority status:
62/826,288 (US)29 March 2019 (29.03.2019) Priority document received (in compliance with PCT Rule 17.1)

(51) International Patent Classification:
A61K 39/395 (2006.01); C07K 16/18 (2006.01)

(71) Applicant(s):
UNIVERSITY OF MASSACHUSETTS [US/US]; 225 Franklin Street, 12th Floor Boston, MA 02110 (US) (for all designated states)

(72) Inventor(s):
CAVACINI, Lisa; c/o University of Massachusetts 225 Franklin Street, 12th Floor Boston, MA 02110 (US)
KLEMPNER, Mark S. J.; c/o University of Massachusetts 225 Franklin Street, 12th Floor Boston, MA 02110 (US)

(74) Agent(s):
DECAMP, James D.; Clark & Elbing LLP 101 Federal Street, 15th Floor Boston, MA 02110 (US)

(54) Title (EN): ANTI-POLYMERIC IgA ANTIBODIES AND METHODS OF USE
(54) Title (FR): ANTICORPS IGA ANTI-POLYMÈRES ET MÉTHODES D'UTILISATION

(57) Abstract:
(EN): The invention provides anti-polymeric IgA (plgA) antibodies and methods of using the same.
(FR): L'invention concerne des anticorps IgA anti-polymères (pIgA) et leurs méthodes d'utilisation.

International search report:
Received at International Bureau: 16 July 2020 (16.07.2020) [US]

International Report on Patentability (IPRP) Chapter II of the PCT:
Not available

(81) Designated States:
AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BN, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DJ, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IR, IS, JO, JP, KE, KG, KH, KN, KP, KR, KW, KZ, LA, LC, LK, LR, LS, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PA, PE, PG, PH, PL, PT, QA, RO, RS, RU, RW, SA, SC, SD, SE, SG, SK, SL, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, WS, ZA, ZM, ZW
European Patent Office (EPO) : AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR
African Intellectual Property Organization (OAPI) : BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, KM, ML, MR, NE, SN, TD, TG
African Regional Intellectual Property Organization (ARIPO) : BW, GH, GM, KE, LR, LS, MW, MZ, NA, RW, SD, SL, ST, SZ, TZ, UG, ZM, ZW
Eurasian Patent Organization (EAPO) : AM, AZ, BY, KG, KZ, RU, TJ, TM

Declarations:
Declaration made as applicant's entitlement, as at the international filing date, to apply for and be granted a patent (Rules 4.17(ii) and 51bis.1(a)(ii)), in a case where the declaration under Rule 4.17(iv) is not appropriate
Declaration of inventorship (Rules 4.17(iv) and 51bis.1(a)(iv)) for the purposes of the designation of the United States of America